OMEPRAZOLE EXTENDED-RELEASE CAPSULES

The contract SPE2DP26F6839, awarded on June 29, 2026, to DMS PHARMACEUTICAL GROUP INC with CAGE code 1UNB0, is a delivery order under the basic indefinite-delivery indefinite-quantity contract SPE2DX25D9900 issued by the Defense Logistics Agency. It covers the procurement of 10 bottles of OMEPRAZOLE EXTENDED-RELEASE CAPSULES, identified by NSN 6505013142716 and NDC number NDC00186-0742-31, at a unit price of $43.60, for a total contract value of $436.00. The delivery is due on or before the award date with FOB Destination terms, meaning the contractor assumes all freight costs and risks until delivery is completed at the specified destination: W91M1Z, 9141 SANSONE, FORT LEWIS WA 98433-9500. No quantity variance is permitted, and substitution is allowed under RANK 01 designation. The contractor must ship via the fastest traceable means and is prohibited from using parcel post. Packaging and labeling must include the NSN, NDC, manufacturer CAGE codes 1AK01, 0THL4, and other relevant identifiers, along with the full MARKFOR address, though no specific preservation, packaging standards, or barcoding requirements are detailed. Invoicing must comply with DFARS 252.232-7003 for electronic submission to the Defense Finance and Accounting Service in Columbus, Ohio. Inspection and acceptance occur at the destination by the government, and the item must conform to the contract without exceptions noted. The contracting officer is Lisa Quinn, with administrative support provided by Shairy M. Cartagena, while the NAICS code 424210 applies. The award appears to be a direct, single-source administrative action with no solicitation, evaluation factors, or socioeconomic certifications disclosed, reflecting a low-dollar, routine pharmaceutical procurement under an existing IDIQ vehicle.